Articles in section Mergers & Acquisitions
| << Licensing | 650 articles | Opinion & Analysis >> |
| Pages 1 2 3 4 5 .. 65 | Next >> |
-
Merck & Co. to Acquire Caraway Therapeutics for Up to US$610 M
-
Basilea Pays US$37 M Upfront for Antifungal from Pfizer’s Amplyx
-
Roche Pays US$7.1 B for Bowel Disease Drug from Roivant and Pfizer
-
Novo Nordisk to Acquire Ocedurenone for Hypertension from KBP Biosciences
-
Alfasigma to Acquire Intercept Pharmaceuticals to Expand into Liver Diseases
-
Kyowa Kirin to Acquire Orchard Therapeutics for US$477.6 M
-
Eli Lilly to Acquire Point Biopharma to Strengthen its Oncology Portfolio
-
Bristol Myers Squibb to Acquire Mirati Therapeutics for Up to US$5.8 B
-
Regeneron Buys Partner Decibel Therapeutics for Up to US$213 M
-
Biogen to Acquire Reata for US$7.3 B for Rare Disease Portfolio
RSS